| ¿µ¹® | neurotransmitter | ÇÑ±Û | ½Å°æÀü´Þ¹°Áú |
|---|---|---|---|
| ¼³¸í | ü³»ÀÇ ½Å°æ ¼¼Æ÷¿¡¼ ¹æÃâµÇ¸ç ÀÎÁ¢ÇÏ´Â ½Å°æ¼¼Æ÷³ª ±ÙÀ°¿¡ Á¤º¸¸¦ Àü´ÞÇÏ´Â ¹°Áú. ½Å°æ¼¼Æ÷³»¿¡¼ ÇÕ¼ºµÇ¾î¼ ½Å°æÁ¾¸»ÀÇ ¿¬Á¢¼ÒÆ÷¿¡ ÀúÀåµÈ´Ù. Àڱؿ¡ ÀÇÇØ¼ ¿¬Á¢°£±Ø¿¡ À¯¸®µÇ¾î¼ ¼ö¿ëü¿Í °áÇÕÇÏ¿© Á¤º¸¸¦ ´ÙÀ½ ¼¼Æ÷·Î ÀüÇÑ´Ù. Àü±âÀûÀ¸·Î°¡ ¾Æ´Ï¶ó ÈÇй°Áú¿¡ ÀÇÇØ¼ ¿¬Á¢°£±ØÀ» °ÅÃÄ Á¤º¸¸¦ ÀüÇϱ⠶§¹®¿¡ ÈÇÐÀü´Þ¹°ÁúÀ̶ó°íµµ ÇÑ´Ù. ¿¬Á¢Èĸ·(°æ¿ì¿¡ µû¶ó¼ ¿¬Á¢Àü¸·)À» ÈïºÐ(Å»ºÐ±Ø)½ÃŰ´Â ÈïºÐ¼ºÀü´Þ¹°Áú°ú ¾ïÁ¦(°úºÐ±Ø)ÇÏ´Â ¾ïÁ¦¼º Àü´Þ¹°ÁúÀÌ ÀÖ´Ù. ¾Æ¼¼Æ¿Äݸ°, ³ë¸£¿¡Çdz×ÇÁ, µµÆÄ¹Î, ±Û¸®½Å, ¥ã-¾Æ¹Ì³ëºäÄ¥»ê(GABA)µî °°Àº ½Å°æÀü´Þ¹°ÁúÀÌ¶óµµ ¼ö¿ëü¿¡ µû¶ó¼ ÈïºÐ¼º°ú ¾ïÁ¦¼ºÀ¸·Îµµ ÀÛ¿ëÇÏ´Â °Íµµ ÀÖ´Ù. |
||
| ¿µ¹® | serum proteins | ÇÑ±Û | Ç÷û´Ü¹é |
|---|---|---|---|
| ¼³¸í | Ç÷û¿¡ ÀÖ´Â ´Ü¹éÁúµéÀ» ÃÑĪÇÏ´Â ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©ÇÏ´Â Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| TM | technology management; tectorial membrane; temperature by mouth; temporalis muscle; temporomandibula... |
|---|---|
| NT, Nt | NeuroTransmitter |
| BNT | Boston Naming Test; brain neurotransmitter |
| PBPs | Penicillin-Binding Proteins |
| PVM | pneumonia virus of mice; proteins, vitamins, and minerals |
| G proteins | GIP-binding proteins |
|---|---|
| G-proteins | GTP)-binding regulatory proteins |
| G-proteins | Guanine nucleotide-binding regulatory proteins |
| G proteins | reglatory proteins |
| CTE | Constitutive Transport Element |
| cholesterol ester transport proteins | A protein that transports cholesterol esters from HDL to VLDL and LDL; a deficiency of this protein is associated with elevated HDL cholesterol. (05 Mar 2000) |
|---|---|
| monosaccharide transport proteins | Membrane transport proteins which bind glucose and sodium ions and enter the cell together. The sodium ions are then pumped out of the cell by a sodium potassium atpase. The rate and extent of the sugar transport depends on the sodium ion concentration. Inhibitors of the monosaccharide transport system are phlorizin, cytochalasin b, and inhibitors of the sodium potassium atpase system. Insulin increases the rate of monosaccharide transport across the membrane into the cell. (12 Dec 1998) |
| receptors, neurotransmitter | Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behaviour of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses. (12 Dec 1998) |
| peptide neurotransmitter | Small peptides used as primary or co transmitters in nerve cells for example FMRF amide, FLRFamide. (18 Nov 1997) |
| neurotransmitter | Any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, y aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin. (18 Nov 1997) |
| neurotransmitter agents | Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (12 Dec 1998) |
| neurotransmitters and neurotransmitter agents | A collective grouping for neurotransmitters and substances that act on the neurotransmitter system. (12 Dec 1998) |
| neurotransmitter system | A group of nerve cells that use the sameneurotransmitter to communicate. (22 May 1997) |
| neurotransmitter uptake inhibitors | Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. (12 Dec 1998) |
| active transport | <biochemistry, chemistry> Transport of ions, nutrients or other molecules into a cell against a concentration gradient, this requires the expenditure of energy through ATP hydrolysis. (06 May 1997) |
| anterograde transport | Movement of material from the cell body of a neuron into axons and dendrites retrograde axoplasmic transport also occurs). (18 Nov 1997) |
| atrial transport function | The role of the atria in filling and stretching the ventricles by their presystolic contraction, without which the force of ventricular contraction and hence the cardiac output may significantly decrease. (05 Mar 2000) |
| axonal transport | Directed transport of organelles and molecules along a nerve cell axon. Transport can be anterograde (from the cell body) or retrograde (toward the cell body). (alberts et al., molecular biology of the cell, 3d ed, pg3) (12 Dec 1998) |
| axoplasmic transport | Transport by way of flow of axoplasm toward cell soma (retrograde) or toward axon terminal (anterograde). (05 Mar 2000) |
| biological transport | The movement of materials (including biochemical substances and drugs) across cell membranes and epithelial layers, usually by passive diffusion. (12 Dec 1998) |
Synonyms : Neurotransmitter Transporter Proteins, Transport Proteins, Neurotransmitter, Transporter Proteins, Neurotransmitter, Transporters, Neurotransmitter
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|